Xolair 150 MG/1.2 ML powder VLS
Ended Awarded
- Contract number
- SPE2DB25FPRC8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,138
Award facts
- Contract value 100% obligated
- $37,137.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 13, 2025, for the supply of Xolair 150 mg/1.2 ml powder vials. This firm fixed-price delivery order carries a ceiling value of $37,137.60 and is scheduled for completion by September 4, 2025. The award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits as an established federal supplier. The place of performance is located in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which carries a single-award value of $499,999,999 through November 2026. This IDC framework enables the DLA to issue firm fixed-price delivery orders for a comprehensive portfolio of pharmaceutical products supporting military healthcare facilities nationwide. Xolair, a biologic medication used in allergy and immunology treatment, represents one of the specialized pharmaceutical products within the company's established federal distribution network serving Department of Defense healthcare sites globally.
Quick answers
Who was awarded contract SPE2DB25FPRC8?
SPE2DB25FPRC8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 13, 2025.
How much is contract SPE2DB25FPRC8 worth?
The government has obligated $37,138 on SPE2DB25FPRC8.
Is contract SPE2DB25FPRC8 an order under another contract?
Yes. SPE2DB25FPRC8 is a delivery order under SPE2DB20D9127, an indefinite delivery contract.
Was contract SPE2DB25FPRC8 competed?
The extent of competition for SPE2DB25FPRC8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award